Benjamin Edwards Inc. lifted its holdings in McKesson Co. (NYSE:MCK – Free Report) by 24.2% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,723 shares of the company’s stock after buying an additional 725 shares during the quarter. Benjamin Edwards Inc.’s holdings in McKesson were worth $2,174,000 at the end of the most recent quarter.
Other institutional investors have also made changes to their positions in the company. Sachetta LLC bought a new position in shares of McKesson in the fourth quarter valued at about $27,000. LRI Investments LLC bought a new position in shares of McKesson in the first quarter valued at about $28,000. Register Financial Advisors LLC bought a new position in shares of McKesson in the first quarter valued at about $29,000. Richardson Financial Services Inc. bought a new position in shares of McKesson in the fourth quarter valued at about $31,000. Finally, Carolinas Wealth Consulting LLC raised its holdings in shares of McKesson by 42.9% in the fourth quarter. Carolinas Wealth Consulting LLC now owns 80 shares of the company’s stock valued at $37,000 after buying an additional 24 shares during the last quarter. 85.07% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of research firms recently issued reports on MCK. Evercore ISI cut their price target on McKesson from $660.00 to $630.00 and set an “outperform” rating for the company in a report on Thursday, August 8th. Citigroup lowered their price objective on McKesson from $670.00 to $630.00 and set a “buy” rating for the company in a research report on Tuesday, September 10th. JPMorgan Chase & Co. lifted their price objective on McKesson from $656.00 to $661.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 21st. Wells Fargo & Company lowered their price objective on McKesson from $576.00 to $535.00 and set an “equal weight” rating for the company in a research report on Friday, September 13th. Finally, Leerink Partners lowered their price objective on McKesson from $670.00 to $665.00 and set an “outperform” rating for the company in a research report on Thursday, September 5th. Two equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $620.93.
McKesson Trading Down 0.7 %
McKesson stock opened at $507.95 on Friday. The firm has a market capitalization of $66.00 billion, a P/E ratio of 22.70, a PEG ratio of 1.18 and a beta of 0.44. McKesson Co. has a 1 year low of $431.35 and a 1 year high of $637.51. The business has a 50-day moving average of $561.63 and a 200-day moving average of $557.00.
McKesson (NYSE:MCK – Get Free Report) last issued its quarterly earnings data on Wednesday, August 7th. The company reported $7.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.21 by $0.67. McKesson had a negative return on equity of 242.57% and a net margin of 0.94%. The business had revenue of $79.28 billion during the quarter, compared to analyst estimates of $82.53 billion. During the same period in the previous year, the firm earned $7.27 EPS. McKesson’s quarterly revenue was up 6.4% compared to the same quarter last year. Research analysts anticipate that McKesson Co. will post 32.11 EPS for the current fiscal year.
McKesson Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 1st. Investors of record on Monday, September 2nd will be given a $0.71 dividend. The ex-dividend date of this dividend is Friday, August 30th. This is a positive change from McKesson’s previous quarterly dividend of $0.62. This represents a $2.84 annualized dividend and a dividend yield of 0.56%. McKesson’s payout ratio is currently 12.69%.
Insider Activity at McKesson
In related news, CEO Brian S. Tyler sold 3,753 shares of the business’s stock in a transaction that occurred on Monday, August 5th. The stock was sold at an average price of $626.03, for a total value of $2,349,490.59. Following the completion of the transaction, the chief executive officer now directly owns 82,339 shares in the company, valued at approximately $51,546,684.17. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In the last three months, insiders sold 11,259 shares of company stock worth $6,635,492. 0.11% of the stock is owned by company insiders.
About McKesson
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.
Featured Stories
- Five stocks we like better than McKesson
- Bank Stocks – Best Bank Stocks to Invest In
- Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
- How to Use the MarketBeat Dividend Calculator
- How the Fed’s Rate Cut Could Supercharge These 3 ETFs
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Microsoft Stock: 3 Reasons It’s Ready to Crush Q4
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK – Free Report).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.